Law360 Healthcare Authority: Healthcare Authority Deals & Corporate Governance /healthcare-authority/deals-corporate-governance?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Healthcare Authority Deals & Corporate Governance Copyright 2025 sa¹ú¼Ê´«Ã½. en-US Fri, 14 Nov 2025 14:40:44 +0000 Richards Layton Seeks $36M In Home-Health Poaching Case /healthcare-authority/deals-corporate-governance/articles/2410887?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2410887 Richards Layton & Finger PA asked the Delaware Chancery Court to award $36.04 million in attorneys' fees and expenses following a poaching case involving home health and hospice companies, arguing that the defendants' pervasive bad-faith conduct requires full fee-shifting under the court's 2024 posttrial ruling. Fri, 14 Nov 2025 14:31:14 +0000 Taxation With Representation: Wachtell, Paul Hastings, Sidley /healthcare-authority/deals-corporate-governance/articles/2411342?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2411342 In this week's Taxation With Representation, Pfizer Inc. completes its acquisition of obesity drug developer Metsera Inc., motion and controls technologies company Parker-Hannifin Corp. acquires Filtration Group Corp., and fund administrator JTC PLC backs a cash offer in the billions from British private equity shop Permira. Fri, 14 Nov 2025 12:19:21 +0000 Gibson Dunn, Cooley Guide Merck's $9.2B Cidara Buy /healthcare-authority/deals-corporate-governance/articles/2411184?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2411184 Gibson Dunn & Crutcher LLP-advised Merck on Friday said it will broaden its respiratory portfolio with a $9.2 billion deal to buy Cooley LLP-led Cidara Therapeutics, betting that an investigational antiviral could help the company tackle the global health burden of seasonal influenza. Thu, 13 Nov 2025 20:29:48 +0000 2nd Circ. Revives Bright Health Investors' Pandemic Suit /healthcare-authority/deals-corporate-governance/articles/2410763?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2410763 The Second Circuit on Thursday revived a suit alleging healthcare management services company Bright Health Group Inc. misled investors in its 2021 initial public offering about its anticipated costs during the COVID-19 pandemic, finding that the complaint plausibly alleged the defendants hid preexisting operational issues and risks. Thu, 13 Nov 2025 20:01:10 +0000 NC Biz Court Bulletin: Rulings Spotlight Coverage Clashes /healthcare-authority/deals-corporate-governance/articles/2411026?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2411026 The North Carolina Business Court plowed into the fourth quarter with two big decisions in insurance disputes that involved $50 million in COVID-19-related losses at a chain of outlet malls, and an industrial accident at a Nucor Corp. iron plant in Louisiana. Thu, 13 Nov 2025 17:52:26 +0000 Fenwick, WilmerHale Steer $285M Mersana Take-Private Deal /healthcare-authority/deals-corporate-governance/articles/2410601?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2410601 Pediatric cancer-focused biopharmaceutical company Day One Biopharmaceuticals, led by Fenwick & West LLP, announced plans Thursday to acquire clinical-stage biopharmaceutical company Mersana Therapeutics Inc., advised by WilmerHale, in a take-private deal worth up to $285 million. Thu, 13 Nov 2025 16:52:28 +0000 Wachtell-Led Pfizer Closes Metsera Deal Worth Up To $10B /healthcare-authority/deals-corporate-governance/articles/2410724?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2410724 Pfizer Inc. said Thursday that it has successfully completed its acquisition of Metsera Inc., securing the obesity drug developer after a tumultuous bidding war with Novo Nordisk and court fights that redirected the deal in Pfizer's favor. Thu, 13 Nov 2025 16:30:57 +0000 FTC Fails To Block Doctors' Testimony In $945M Merger Case /healthcare-authority/deals-corporate-governance/articles/2409166?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2409166 A D.C. federal judge refused Thursday to bar a pair of outside doctors and consultants from vouching for Edwards Lifesciences Corp.'s planned JenaValve Technology Inc. acquisition, preferring to let the Federal Trade Commission contest their testimony in cross-examination and saying from the bench that he'll "make some popcorn." Thu, 13 Nov 2025 15:10:05 +0000 DocGo Investors Seek OK Of $12.5M Deal Over Ex-CEO Claims /healthcare-authority/deals-corporate-governance/articles/2410517?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2410517 Investors of mobile medical provider DocGo have asked a New York federal court to grant preliminary approval of their $12.5 million settlement of claims that the company deceived stockholders before a $432 million contract with New York City to provide emergency migrant housing came under public scrutiny. Thu, 13 Nov 2025 14:18:28 +0000 Virtua, Trinity Health Reach Deal Over $12M Legal Bill /healthcare-authority/deals-corporate-governance/articles/2410780?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2410780 Virtua Health Inc. has reached a deal to settle its claims that Trinity Health Corp. backed out of an agreement to cover $12 million in counsel fees and costs incurred in a legal fight with a rival healthcare system, according to a New Jersey federal court order dismissing the suit with prejudice. Wed, 12 Nov 2025 20:36:24 +0000 Sandoz Tells 3rd Circ. To Restore Full $137M Win Over UTC /healthcare-authority/deals-corporate-governance/articles/2410205?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2410205 Sandoz Inc. and its marketing firm RareGen LLC urged a Third Circuit panel on Wednesday to reinstate the full $137.2 million awarded in breach of contract damages against United Therapeutics Corp., claiming a lower court's decision to halve the damages provided a windfall to their adversary. Tue, 11 Nov 2025 20:00:26 +0000 Law360 MVP Awards Go To Top Attorneys From 76 Firms /healthcare-authority/deals-corporate-governance/articles/2406818?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2406818 The attorneys chosen as Law360's 2025 MVPs have distinguished themselves from their peers by securing significant achievements in high-stakes litigation, complex global matters and record-breaking deals. Tue, 11 Nov 2025 13:18:14 +0000 Joint Operating Deals Get Another Look in Hospital Tie-Ups /healthcare-authority/deals-corporate-governance/articles/2409414?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2409414 Interest in joint operating agreements — sometimes called virtual mergers — is on the rise as more hospitals try to prepare for heavier industry headwinds and the effects of the 2025 federal budget bill. Mon, 10 Nov 2025 18:20:14 +0000 Acadia Healthcare Inks Investor Settlement Days Before Trial /healthcare-authority/deals-corporate-governance/articles/2409268?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2409268 Acadia Healthcare Co. Inc. and plaintiffs in a securities class action accusing the company of misleading investors about the strength of its United Kingdom operations have reached a settlement in principle, avoiding a trial that was set for later this month. Mon, 10 Nov 2025 16:52:17 +0000 FTC Risks Help Push Metsera Back To Pfizer /healthcare-authority/deals-corporate-governance/articles/2409291?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2409291 Novo Nordisk AS' aspirations to pry Metsera away from Pfizer Inc. collapsed over the weekend under the pressure of a revised Pfizer offer, twin court challenges and "a call from the U.S. Federal Trade Commission." Fri, 07 Nov 2025 20:30:36 +0000 Sleep Apnea Device Co. Investor Says Rollout Was Botched /healthcare-authority/deals-corporate-governance/articles/2408694?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2408694 Medical device company Inspire Medical Systems has been hit with a proposed investor class action alleging its shares dropped by nearly a third of their value after the public learned it concealed low demand and rollout shortcomings associated with its newest sleep apnea device. Fri, 07 Nov 2025 19:39:41 +0000 Spurned Pfizer Turns To Antitrust Law To Reclaim Biotech /healthcare-authority/deals-corporate-governance/articles/2407549?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2407549 What may be a first-of-its-kind lawsuit is playing out as Pfizer Inc. turns to antitrust law to keep Novo Nordisk from usurping its bid for Metsera. Fri, 07 Nov 2025 14:19:43 +0000 Taxation With Representation: Kirkland, Cravath, Paul Weiss /healthcare-authority/deals-corporate-governance/articles/2408937?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2408937 In this week's Taxation With Representation, consumer products giant Kimberly-Clark acquires Tylenol maker Kenvue, shale producers SM Energy and Civitas Resources announce a merger, and power management company Eaton buys Boyd Corp.'s thermal business. Thu, 06 Nov 2025 20:34:42 +0000 Debt Collectors Sue Over Colo.'s Medical Debt Reporting Ban /healthcare-authority/deals-corporate-governance/articles/2408053?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2408053 A major debt collection trade group sued to block a Colorado law banning medical debt from credit reports, arguing it conflicts with a federal law that the Consumer Financial Protection Bureau recently said doesn't let states regulate credit report content. Thu, 06 Nov 2025 16:42:16 +0000 Edwards Defends $945M Heart Valve Deal From FTC Challenge /healthcare-authority/deals-corporate-governance/articles/2408343?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2408343 Edwards Lifesciences urged a D.C. federal court to reject the Federal Trade Commission's bid to put its planned $945 million acquisition of JenaValve on hold, saying the deal will increase innovation and save the lives of thousands of people with a form of heart valve disease.